Micron Technology Surges as UBS Triples Price Target on AI Demand Nears 1 Trillion Valuation Trump Seeks Supreme Court Intervention to Halt TikTok Ban Vegorama Punjabi Angithi IPO Allotment Likely Today Subscription Hit 35 Times Standard Chartered CEO Apologizes for LowerValue Human Capital Remark Amid AIDriven Job Cuts Prediction Markets Signal Growing Odds of Fed Rate Hike by July 2027 Horchata Emerges as Next Big Beverage Trend in Foodservice Industry TRVI Q1 2026 Earnings WiderthanExpected Loss Amid PreRevenue Development Stage MKC Q1 2026 Earnings Strong EPS Beat Amid Market Challenges Pathward Financial Inc CASH Q1 2026 Earnings EPS Misses Estimates by 254 Stock Holds Steady Essential Properties Realty Trust Q1 2026 Earnings EPS Misses Estimates as Net Income Declines UFPI Q1 2026 Earnings Earnings Miss Weighs on Shares Despite Stable Operations SPRB Q1 2026 Earnings Narrower Than Expected Loss Drives Positive Sentiment Urban Edge Properties UE Posts Slight Gain as Stock Holds Above Support Level Millennium Group International MGIH Edges Lower Amidst Consolidation Near Key Support Guidewire Software GWRE Climbs 335 as Support Holds and Resistance Looms Ooma Inc OOMA Advances 169 Testing Resistance at 1862 as Volume Builds China SXT Pharmaceuticals SXTC Slips 3 as Stock Tests Key Support Levels Senegal Political Turmoil Deepens as Parliament Speaker Resigns Fueling Leadership Uncertainty ADXN Q1 2024 Earnings ClinicalStage Biotech Reports Net Loss as Pipeline Advances Ferroglobe GSM Slides 221 Testing Support Near 399 RMCF Q1 2026 Earnings Loss per Share Narrows as Stock Gains 415 Cathay General Bancorp CATY Q1 2026 Earnings Strong EPS Surprise of 2275 Drives Profit Beat Despite Stock Dip HSIC Q1 2026 Earnings EPS Beat of 631 Surprises Analysts Banc of California Inc BANC Q1 2026 Earnings EPS Surpasses Estimates Amid Solid Operating Performance CHDN Q1 2026 Earnings EPS Beats Estimates by 182 Stock Edges Lower Fox Corporation FOXA Q1 2026 Earnings Strong EPS Beat Drives Positive Surprise but Stock Edges Lower Telomir Pharmaceuticals TELO Q4 2025 Earnings WiderthanExpected Loss Amid Ongoing Development